Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 777 to 826 of 8289 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
389\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein cux-2 (cut-like 2) (fragment). [source:swissprot;acc:o14529]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8159.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8595.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05333\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
probable atp-dependent rna helicase p54 (oncogene rck) (dead-box protein 6). [source:swissprot;acc:p26196]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4533.74\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
5279.4\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.16447\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
390\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
rw1 protein (fragment). [source:swissprot;acc:q92545]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
toll-like receptor 2 precursor (toll/interleukin 1 receptor-like protein 4). [source:swissprot;acc:o60603]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6983.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7354.87\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05318\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
391\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
tar dna-binding protein-43 (tdp-43). [source:swissprot;acc:q13148]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3658.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3144.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16358\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar proton translocating atpase 116 kda subunit a isoform 1 (clathrin-coated vesicle/synaptic vesicle proton pump 116 kda subunit) (vacuolar proton pump subunit 1) (vacuolar adenosine triphosphatase subunit ac116). [source:swissprot;acc:q93050]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8552.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9004.53\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05289\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
392\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-dependent rna helicase mgc2835; atp-dependent rna helicase; apoptosis related protein apr-5; dead box helicase 97 kda. [source:refseq;acc:nm\_024072]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3641.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4236.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16339\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein sm d2 (snrnp core protein d2) (sm-d2). [source:swissprot;acc:p43330]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7781.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8192.41\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.05283\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
393\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cryptochrome 1 (photolyase-like). [source:refseq;acc:nm\_004075]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8673.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9132.05\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 4e (eif-4e) (eif4e) (mrna cap-binding protein) (eif-4f 25 kda subunit). [source:swissprot;acc:p06730]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4490.28\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
5222.25\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.16301\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
394\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bai1-associated protein 3; bai-associated protein 3. [source:refseq;acc:nm\_003933]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative dimethylaniline monooxygenase [n-oxide forming] 6 (ec 1.14.13.8) (flavin-containing monooxygenase 6) (fmo 6) (dimethylaniline oxidase 6). [source:swissprot;acc:o60774]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7679.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8084.79\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05279\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
395\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
atpase, h+ transporting, lysosomal v0 subunit a isoform 4; vacuolar proton pump 116 kda accessory subunit; vacuolar proton pump, subunit 2; h(+)-transporting two-sector atpase, noncatalytic accessory protein 1b; atpase, h+ transporting, lysosomal (vacuolar proton pump) non-catalytic accessory protein 1b; renal tubular acidosis; atpase, h+ transporting, lysosomal (vacuolar proton pump) non-catalytic accessory protein 2 (38kd). [source:refseq;acc:nm\_020632]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8552.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9003.72\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05278\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor 4 isoform b; rna-binding protein. [source:refseq;acc:nm\_021164]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4532.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5269.33\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16251\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
396\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 3 (ec 1.14.13.8) (hepatic flavin-containing monooxygenase 3) (fmo 3) (dimethylaniline oxidase 3) (fmo form 2) (fmo ii). [source:swissprot;acc:p31513]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7680.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8085.19\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05276\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ribonucleotide reductase m2 b (tp53 inducible); p53-inducible ribonucleotide reductase small subunit 2 homolog. [source:refseq;acc:nm\_015713]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6563.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7627.29\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16205\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
397\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 2 (ec 1.14.13.8) (pulmonary flavin-containing monooxygenase 2) (fmo 2) (dimethylaniline oxidase 2) (fmo 1b1). [source:swissprot;acc:q99518]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7679.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8084.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05275\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear protein skip (ski-interacting protein) (snw1 protein) (nuclear receptor coactivator ncoa-62). [source:swissprot;acc:q13573]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5367.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6233.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16137\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
398\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 1 (ec 1.14.13.8) (fetal hepatic flavin-containing monooxygenase 1) (fmo 1) (dimethylaniline oxidase 1). [source:swissprot;acc:q01740]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7680.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8085.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05273\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
xpa-binding protein 2 (hcnp protein) (pp3898). [source:swissprot;acc:q9hcs7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5084.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5904.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16125\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
399\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 4 (ec 1.14.13.8) (hepatic flavin-containing monooxygenase 4) (fmo 4) (dimethylaniline oxidase 4). [source:swissprot;acc:p31512]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7680.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8085.57\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05272\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal acetylcholine receptor protein, alpha-7 chain precursor. [source:swissprot;acc:p36544]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5201.41\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
4479.76\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.16109\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
400\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenylate cyclase, type vi (ec 4.6.1.1) (atp pyrophosphate-lyase) (ca(2+)-inhibitable adenylyl cyclase). [source:swissprot;acc:o43306]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mad protein (max dimerizer). [source:swissprot;acc:q05195]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6970.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7337.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05272\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
401\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenylate cyclase, type v (ec 4.6.1.1) (atp pyrophosphate-lyase) (adenylyl cyclase) (fragment). [source:swissprot;acc:o95622]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5201.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4479.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16109\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
gdp-mannose pyrophosphorylase a; mannose-1-phosphate guanylyltransferase (gdp). [source:refseq;acc:nm\_013335]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10800.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10260\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0527\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
402\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
leucine-rich repeat-containing protein 15 precursor (hlib). [source:swissprot;acc:q8tf66]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5201.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4479.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16109\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
squamous cell carcinoma antigen recognized by t cells 1; u4/u6.u5 tri-snrnp-associated 110 kda protein; ige autoantigen; sart1(259) protein; sart1(800) protein. [source:refseq;acc:nm\_005146]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7934.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8352.26\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05269\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
403\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fem-1 homolog b; fem-1-like death receptor binding protein; fem-1 (c.elegans) homolog b. [source:refseq;acc:nm\_015322]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5201.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4479.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16109\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
seryl-trna synthetase, mitochondrial precursor (ec 6.1.1.11) (serine--trna ligase) (serrsmt). [source:swissprot;acc:q9np81]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8853.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9319.56\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05269\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
404\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin-like protein kif23 (mitotic kinesin-like protein-1) (kinesin- like protein 5). [source:swissprot;acc:q02241]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
10008.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9508.16\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05265\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
leucine-rich repeat protein lrrc3 precursor. [source:swissprot;acc:q9by71]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5201.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4479.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16109\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
405\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cylindromatosis (turban tumor syndrome); cylindromatosis 1, turban tumor syndrome. [source:refseq;acc:nm\_015247]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10008.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9508.16\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05265\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
laminin gamma-1 chain precursor (laminin b2 chain). [source:swissprot;acc:p11047]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5201.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4479.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16109\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
406\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
l-lactate dehydrogenase a-like (ec 1.1.1.27). [source:swissprot;acc:q9byz2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6973.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7340.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05264\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
thymic stromal co-transporter. [source:refseq;acc:nm\_033051]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5201.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4479.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16109\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
407\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase 18 kda subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-18 kda) (ci-18 kda) (complex i- aqdq) (ci-aqdq). [source:swissprot;acc:o43181]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6634.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6983.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05264\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
wiskott-aldrich syndrome protein interacting protein (wasp interacting protein) (prpl-2 protein). [source:swissprot;acc:o43516]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6603.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7664.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16071\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
408\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dok-like protein. [source:refseq;acc:nm\_024872]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6102.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7081.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1604\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
l-lactate dehydrogenase c chain (ec 1.1.1.27) (ldh-c) (ldh testis subunit) (ldh-x). [source:swissprot;acc:p07864]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6973.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7340.35\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05263\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
409\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
docking protein 2 (p56(dok-2)) (downstream of tyrosine kinase 2). [source:swissprot;acc:o60496]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6102.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7081.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1604\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
l-lactate dehydrogenase a chain (ec 1.1.1.27) (ldh-a) (ldh muscle subunit) (ldh-m). [source:swissprot;acc:p00338]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6973.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7340.36\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05263\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
410\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
docking protein 1 (p62(dok)) (downstream of tyrosine kinase 1) (pp62). [source:swissprot;acc:q99704]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6102.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7081.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1604\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
max interacting protein 1 (mxi1 protein). [source:swissprot;acc:p50539]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6973.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7340.61\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.05263\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
411\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
l-lactate dehydrogenase b chain (ec 1.1.1.27) (ldh-b) (ldh heart subunit) (ldh-h). [source:swissprot;acc:p07195]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6973.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7340.39\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosine-protein kinase frk (ec 2.7.1.112) (nuclear tyrosine protein kinase rak). [source:swissprot;acc:p42685]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6102.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7081.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1604\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
412\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
clip-associating protein 1; drosophila 'multiple asters' (mast)-like homolog 1. [source:refseq;acc:nm\_015282]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6973.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7340.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05263\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mki67 (fha domain) interacting nucleolar phosphoprotein; nucleolar phosphoprotein nopp34; nucleolar protein interacting with the fha domain of pki-67. [source:refseq;acc:nm\_032390]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3594.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4169.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16015\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
413\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
max-interacting transcriptional repressor mad4 (max-associated protein 4) (max dimerization protein 4). [source:swissprot;acc:q14582]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6974.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7341.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05259\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vav proto-oncogene. [source:swissprot;acc:p15498]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6644.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7707.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15994\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/